Digesta viscosity and pH in the ileum. by Miloš Skřivan (5122037)

“…Xylanase significantly decreased the intake of feed (p < 0.001), decreased feed conversion (p < 0.001), and reduced mortality (p = 0.050). …”

Nutrient retention in broilers (g/kg/day). by Miloš Skřivan (5122037)

“…Xylanase significantly decreased the intake of feed (p < 0.001), decreased feed conversion (p < 0.001), and reduced mortality (p = 0.050). …”

Fatty acid composition (mg/100 g) of breast meat. by Miloš Skřivan (5122037)

“…Xylanase significantly decreased the intake of feed (p < 0.001), decreased feed conversion (p < 0.001), and reduced mortality (p = 0.050). …”

Fat contents (g/kg) in breast meat and liver. by Miloš Skřivan (5122037)

“…Xylanase significantly decreased the intake of feed (p < 0.001), decreased feed conversion (p < 0.001), and reduced mortality (p = 0.050). …”

Growth and color data for all specimens and tank temperature and pH conditions. by Teagan McMahon (20108036)

Changes in alpha diversity in the weeks before anti-TNF-a treatment. by Katrine Carlsen (5477300)

“…The analysis found a significant association across all subjects for Shannon diversity with decreasing diversity in the lead up to the next treatment (lmer model, beta = -0.018, <i>p</i> = 0.036) and no association for observed diversity (<i>p</i>>0.1). …”

Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides by Zufang Ba (11036420)

“…Among them, W₃BipY₈-P stood out as the most promising peptide, exhibiting similar antibacterial activity as its unphosphorylated analog W₃BipY₈ but with significantly reduced hemolytic activity (19-fold decrease), cytotoxicity (3.3-fold decrease), and an extended serum half-life 6.3 times longer than W₃BipY₈. …”

Busulfan treatment induces orchitis. by Lingjun Zhao (21763122)

“…<p>(A) Hematoxylin and eosin staining of mouse testis tissue show gradual shedding of spermatogonia and decreases in the seminiferous tubule over time after busulfan treatment. …”

The knockdown efficiency of KIF15 in 293T cells was assessed. by Xiaomei He (795333)

KIF15 mediates the trafficking of PSD95 along microtubules. by Xiaomei He (795333)

The depressive behavior in <i>Kif15</i>^<i>-/-</i> zebrafish was rescued following <i>Kif15</i> supplementation. by Xiaomei He (795333)

Emotional changes in <i>Kif15</i>^<i>-/-</i> mice from adolescence to adulthood. by Xiaomei He (795333)

KIF15 interacts with PSD95 and affect its localization in neuronal cytoplasm neurons of the PFC. by Xiaomei He (795333)

<i>Kif15</i> deficient mice exhibit both depressive and manic behaviors in adulthood. by Xiaomei He (795333)

<i>Kif15</i> deletion results in abnormal distribution of PSD95 in neuropil. by Xiaomei He (795333)

<i>Kif15</i> deficiency affects the expression of Gephyrin and GABRB1 in PFC and hippocampus. by Xiaomei He (795333)

<i>Kif15</i> deficiency affects the expression of excitatory postsynaptic receptors in PFC and hippocampus. by Xiaomei He (795333)

“…<p><b>(A and D)</b>: Western Blot analysis showed decreased protein levels of PSD95 and NMDA receptor GluN2A in the PFC of 3 week-old <i><i>Kif15</i></i>^<i>-/-</i> mice, n = 7 ~ 8 in <i><i>Kif15</i></i>^<i>+/+</i> group, n = 6 in <i><i>Kif15</i></i>^<i>-/-</i> group. …”

Grade system. by Zhuoyang Xia (21354186)

“…Regarding COVID-19 severity, no significant difference were found for asymptomatic (pooled RR 1.18; 95%CI: 0.81–1.72), mild to moderate (pooled RR 0.99; 95%CI: 0.84–1.17), severe COVID-19 (pooled RR 1.25; 95%CI: 0.92–1.70), hospitalization (pooled RR 0.93; 95%CI: 0.58–1.50) or all-cause mortality (pooled RR 0.60; 95%CI: 0.18–1.95) between BCG and placebo groups. …”

Literature search. by Zhuoyang Xia (21354186)

“…Regarding COVID-19 severity, no significant difference were found for asymptomatic (pooled RR 1.18; 95%CI: 0.81–1.72), mild to moderate (pooled RR 0.99; 95%CI: 0.84–1.17), severe COVID-19 (pooled RR 1.25; 95%CI: 0.92–1.70), hospitalization (pooled RR 0.93; 95%CI: 0.58–1.50) or all-cause mortality (pooled RR 0.60; 95%CI: 0.18–1.95) between BCG and placebo groups. …”

Study characteristics. by Zhuoyang Xia (21354186)

“…Regarding COVID-19 severity, no significant difference were found for asymptomatic (pooled RR 1.18; 95%CI: 0.81–1.72), mild to moderate (pooled RR 0.99; 95%CI: 0.84–1.17), severe COVID-19 (pooled RR 1.25; 95%CI: 0.92–1.70), hospitalization (pooled RR 0.93; 95%CI: 0.58–1.50) or all-cause mortality (pooled RR 0.60; 95%CI: 0.18–1.95) between BCG and placebo groups. …”